Walmart Q1 2025 10-Q Filed
Ticker: WMT · Form: 10-Q · Filed: Jun 7, 2024 · CIK: 104169
Sentiment: neutral
Topics: 10-Q, Walmart, debt, financials
TL;DR
Walmart's Q1 2025 10-Q is in, showing debt notes and fiscal year-end details.
AI Summary
Walmart Inc. filed its 10-Q for the period ending April 30, 2024, reporting on its financial performance. The filing details various debt instruments, including "A2.550 Notes Due 2026" and "A5.625 Notes Due 2034", indicating ongoing financial management and capital structure. The company's fiscal year ends on January 31st, with this report covering the first quarter of fiscal year 2025.
Why It Matters
This filing provides insight into Walmart's financial health and debt obligations, which can influence investor confidence and its ability to fund future operations and growth.
Risk Assessment
Risk Level: low — This is a routine quarterly filing that provides standard financial information and does not indicate any unusual or significant risks.
Key Numbers
- 2024-04-30 — Reporting Period End Date (This is the end date for the financial information presented in the 10-Q.)
- 2025-01-31 — Fiscal Year End (Indicates when Walmart's fiscal year concludes.)
Key Players & Entities
- Walmart Inc. (company) — Filer of the 10-Q
- 2024-04-30 (date) — End of the reporting period
- 2025-01-31 (date) — Fiscal year end
- A2.550 Notes Due 2026 (dollar_amount) — Debt instrument mentioned
- A5.625 Notes Due 2034 (dollar_amount) — Debt instrument mentioned
FAQ
What is the primary purpose of this 10-Q filing?
The primary purpose of this 10-Q filing is to provide Walmart Inc.'s quarterly financial performance and condition for the period ending April 30, 2024.
What specific debt instruments are mentioned in the filing?
The filing mentions several debt instruments, including 'A2.550 Notes Due 2026', 'A1050 Notes Due 2026', 'A1500 Notes Due 2028', 'A4875 Notes Due 2029', 'A5750 Notes Due 2030', 'A1800 Notes Due 2031', 'A5625 Notes Due 2034', 'A5250 Notes Due 2035', and 'A4875 Notes Due 2039'.
When does Walmart Inc.'s fiscal year end?
Walmart Inc.'s fiscal year ends on January 31st.
What is the filing date of this 10-Q?
This 10-Q filing was made on June 7, 2024.
What is the SIC code for Walmart Inc.?
The Standard Industrial Classification (SIC) code for Walmart Inc. is 5331, which corresponds to Retail-Variety Stores.
Filing Stats: 4,688 words · 19 min read · ~16 pages · Grade level 14.5 · Accepted 2024-06-07 16:45:14
Key Financial Figures
- $0.10 — ich registered Common Stock, par value $0.10 per share WMT New York Stock Exchange
Filing Documents
- wmt-20240430.htm (10-Q) — 1055KB
- wmtexhibit311fy25q1.htm (EX-31.1) — 8KB
- wmtexhibit312fy25q1.htm (EX-31.2) — 8KB
- wmtexhibit321fy25q1.htm (EX-32.1) — 4KB
- wmtexhibit322fy25q1.htm (EX-32.2) — 4KB
- wmtexhibit991fy25q1.htm (EX-99.1) — 7KB
- wmt-20240430_g1.jpg (GRAPHIC) — 34KB
- 0000104169-24-000105.txt ( ) — 5036KB
- wmt-20240430.xsd (EX-101.SCH) — 32KB
- wmt-20240430_cal.xml (EX-101.CAL) — 56KB
- wmt-20240430_def.xml (EX-101.DEF) — 151KB
- wmt-20240430_lab.xml (EX-101.LAB) — 446KB
- wmt-20240430_pre.xml (EX-101.PRE) — 310KB
- wmt-20240430_htm.xml (XML) — 557KB
Financial Information
Part I. Financial Information
Financial Statements
Item 1. Financial Statements Condensed Consolidated Statements of Income 4 Condensed Consolidated Statements of Comprehensive Income 5 Condensed Consolidated Balance Sheets 6 Condensed Consolidated Statements of Shareholders' Equity 7 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Controls and Procedures
Item 4. Controls and Procedures 27
Other Information
Part II. Other Information
Legal Proceedings
Item 1. Legal Proceedings 28
Risk Factors
Item 1A. Risk Factors 30
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
Other Information
Item 5. Other Information 30
Exhibits
Item 6. Exhibits 34
Signatures
Signatures 35 Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements Walmart Inc. Condensed Consolidated Statements of Income (Unaudited) Three Months Ended April 30, (Amounts in millions, except per share data) 2024 2023 Revenues: Net sales $ 159,938 $ 151,004 Membership and other income 1,570 1,297 Total revenues 161,508 152,301 Costs and expenses: Cost of sales 121,431 115,284 Operating, selling, general and administrative expenses 33,236 30,777 Operating income 6,841 6,240 Interest: Debt 597 568 Finance lease 117 96 Interest income ( 114 ) ( 107 ) Interest, net 600 557 Other (gains) and losses ( 794 ) 2,995 Income before income taxes 7,035 2,688 Provision for income taxes 1,728 792 Consolidated net income 5,307 1,896 Consolidated net income attributable to noncontrolling interest ( 203 ) ( 223 ) Consolidated net income attributable to Walmart $ 5,104 $ 1,673 Net income per common share: Basic net income per common share attributable to Walmart $ 0.63 $ 0.21 Diluted net income per common share attributable to Walmart 0.63 0.21 Weighted-average common shares outstanding: Basic 8,053 8,082 Diluted 8,084 8,112 Dividends declared per common share $ 0.83 $ 0.76 See accompanying notes. 4 Table of Contents Walmart Inc. Condensed Consolidated Statements of Comprehensive Income (Unaudited) Three Months Ended April 30, (Amounts in millions) 2024 2023 Consolidated net income $ 5,307 $ 1,896 Consolidated net income attributable to noncontrolling interest ( 203 ) ( 223 ) Consolidated net income attributable to Walmart 5,104 1,673 Other comprehensive income, net of income taxes Currency translation and other ( 21 ) 811 Cash flow hedges 28 ( 69 ) Other comprehensive income, net of income taxes 7 742 Other comprehensive income attributable to noncontrolling interest ( 72 ) ( 209 ) Other comprehensive income (loss) attributable to Walmart ( 65 ) 533 Comprehensive income, net of income taxes 5,314 2,638 Comprehensive income attributable to noncontrollin
Legal Proceedings
Legal Proceedings The Company is involved in a number of legal proceedings and certain regulatory matters. The Company records a liability for those legal proceedings and regulatory matters when it determines it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses when it is reasonably possible that a material loss may be incurred. From time to time, the Company may enter into discussions regarding settlement of these matters, and may enter into settlement agreements, if it believes settlement is in the best interest of the Company and its shareholders. Unless stated otherwise, the matters discussed below, if decided adversely to or settled by the Company, individually or in the aggregate, may result in a liability material to the Company's financial position, results of operations, or cash flows. The Company can provide no assurance as to the scope and outcome of these matters and cannot reasonably estimate any loss or range of loss, beyond the amounts accrued, if any, that may arise from these matters. Settlement of Certain Opioid-Related Matters TheCompany entered into settlement agreements with all 50 states, the District of Columbia, Puerto Rico, three U.S. territories, and the vast majority of eligible political subdivisions and federally recognized Native American tribes to resolve opioid-related claims against the Company.Remaining eligible political subdivisions and federally recognized Native American tribes haveuntil July 15, 2025andFebruary 24, 2026,respectively, to join these settlements.In fiscal year 2023, the Company accrueda liability of approximately $ 3.3 billion for these settlements, which include amounts for remediation of alleged harms, attorneys' fees, and costs. As of January 31, 2024, substantially all of the approximately $ 3.3 billion accrued liability had been paid. Ongoing Opioid-Related Litigation The Company will continue to vigorously defend against any opi